We found that CRTC3 knockout sensitized HCC cells to sorafenib by reprograming tumor cell lipid metabolism and facilitating ferroptosis, which provides a new clue for optimizing sorafenib treatment. Here, CRTC3 is linked to hepatocellular carcinoma.